Glimepiride sulfonamide
Glimepiride sulfonamide is a intermediate, and can be used to synthesize Glimepiride (HY-B0104) (antidiabetic agent) [1].
Product Specifications
CAS Number
[119018-29-0]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Drug Intermediate
Type
Natural Products
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/glimepiride-sulfonamide.html
Concentration
10mM
Purity
99.90
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=S(C1=CC=C(CCNC(N2C(C(CC)=C(C)C2)=O)=O)C=C1)(N)=O
Molecular Formula
C16H21N3O4S
Molecular Weight
351.43
Precautions
H302, H315, H319, H335
References & Citations
[1]Parmar HS, et al. Study on gluco-regulatory potential of glimepiride sulfonamide using in silico, in vitro and in vivo approaches. Curr Pharm Des. 2014;20 (32) :5212-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1068833-01 0.02 mg (E-Coli)
Recombinant Ochrobactrum anthropi LexA repressor (lexA)
Ask
View Details 
MBS1068833-02 0.1 mg (E-Coli)
Recombinant Ochrobactrum anthropi LexA repressor (lexA)
Ask
View Details MBS1068833-03 0.02 mg (Yeast)
Recombinant Ochrobactrum anthropi LexA repressor (lexA)
Ask
View Details MBS1068833-04 0.1 mg (Yeast)
Recombinant Ochrobactrum anthropi LexA repressor (lexA)
Ask
View Details MBS1068833-05 0.02 mg (Baculovirus)
Recombinant Ochrobactrum anthropi LexA repressor (lexA)
Ask
View Details 
MBS1068833-06 0.02 mg (Mammalian-Cell)
Recombinant Ochrobactrum anthropi LexA repressor (lexA)
Ask
View Details